Location History:
- Germantown, MD (US) (1999)
- Bethesda, MD (US) (2000 - 2004)
- Chevy Chase, MD (US) (2001 - 2015)
- Bryn Mawr, PA (US) (2005 - 2023)
Company Filing History:
Years Active: 1999-2023
Title: **Richard Alan Couch: A Pioneering Inventor in Pharmaceutical Innovations**
Introduction
Richard Alan Couch, an accomplished inventor based in Bryn Mawr, PA, has made significant contributions to the pharmaceutical industry with an impressive portfolio of 17 patents. His innovative research focuses primarily on drug delivery systems and novel pharmaceutical formulations that enhance therapeutic efficacy.
Latest Patents
Couch's latest patents include groundbreaking work on **Solid Forms of Fasoracetam**, which aims to provide cocrystals of fasoracetam, including R-fasoracetam, combined with various coformers. This disclosure not only highlights the crystalline materials comprising fasoracetam but also outlines pharmaceutical compositions and methods for treating conditions using these innovative cocrystals.
Another notable patent is the **Controlled Dose Drug Delivery System**, which introduces a multiple pulsed dose delivery mechanism for pharmaceutical amphetamine salts. This system involves a coating strategy that allows for immediate and enteric release of the active ingredients, thus enabling versatile dosage forms such as capsules, tablets, or sachets.
Career Highlights
Throughout his career, Richard has been associated with renowned organizations such as Shire Laboratories, Inc. and Shire LLC. His work in these companies has greatly contributed to the development of advanced pharmaceutical products that cater to patients’ needs.
Collaborations
Couch has had the opportunity to collaborate with distinguished professionals in the field, including Beth A Burnside and Edward M Rudnic. These collaborations have enriched his research endeavors and facilitated the successful development of his innovative inventions.
Conclusion
Richard Alan Couch stands out as a notable figure in the realm of pharmaceutical inventions, with his significant patents reflecting a deep commitment to advancing drug delivery systems. His continuous contributions to the field underscore the importance of innovation in providing effective healthcare solutions.